| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Gianluigi Zaza | Q37635234 |
| P2093 | author name string | Antonio Lupo | |
| Simona Granata | |||
| Lorenzo Signorini | |||
| P2860 | cites work | The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial | Q21195361 |
| Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses | Q23921756 | ||
| Vitamins C and E: beneficial effects from a mechanistic perspective | Q24617202 | ||
| Effect of allopurinol in chronic kidney disease progression and cardiovascular risk | Q24630327 | ||
| Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis | Q24649875 | ||
| Curcumin attenuates diabetic nephropathy by inhibiting PKC-α and PKC-β1 activity in streptozotocin-induced type I diabetic rats | Q82299221 | ||
| Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis | Q82714205 | ||
| Nutritional compounds influence tissue factor expression and inflammation of chronic kidney disease patients in vitro | Q83374012 | ||
| The effects of dietary fish oil on inflammation, fibrosis and oxidative stress associated with obstructive renal injury in rats | Q83521066 | ||
| Serum selenium levels are inversely associated with death risk among hemodialysis patients | Q83524652 | ||
| Selenium supplementation improves the nutritional status of hemodialysis patients: a randomized, double-blind, placebo-controlled trial | Q84524780 | ||
| Effects of alpha-lipoic acid supplementation on inflammation, oxidative stress, and serum lipid profile levels in patients with end-stage renal disease on hemodialysis | Q84931385 | ||
| Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on arterial compliance and distensibility in patients with mild-to-moderate chronic kidney disease | Q84975490 | ||
| Decreased plasma level of vitamin C in chronic kidney disease: comparison between diabetic and non-diabetic patients | Q84981428 | ||
| L-carnitine for anemia in hemodialysis patients: a last resort | Q85241363 | ||
| n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease | Q85442463 | ||
| Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway | Q85511230 | ||
| Curcumin alleviates immune-complex-mediated glomerulonephritis in factor-H-deficient mice | Q85950139 | ||
| Plasma Xanthine Oxidase Activity Is Predictive of Cardiovascular Disease in Patients with Chronic Kidney Disease, Independently of Uric Acid Levels | Q86348318 | ||
| A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease | Q87178348 | ||
| Effects of vitamin E on peroxisome proliferator-activated receptor γ and nuclear factor-erythroid 2-related factor 2 in hypercholesterolemia-induced atherosclerosis | Q87386181 | ||
| Effects of alpha lipoic acid supplementation on serum levels of IL-8 and TNF-α in patient with ESRD undergoing hemodialysis | Q87675149 | ||
| Epicardial fat tissue thickness is correlated with diminished levels of co-enzyme Q10, a major antioxidant molecule among hemodialysis patients | Q87995087 | ||
| The Green Tea Polyphenol(-)-epigallocatechin-3-gallate and its beneficial roles in chronic kidney disease | Q89260312 | ||
| Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial | Q24654699 | ||
| Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential | Q24658099 | ||
| Vitamin E, antioxidant and nothing more | Q24676043 | ||
| Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease | Q25257027 | ||
| PUFAs: Structures, Metabolism and Functions | Q26771687 | ||
| Mitochondria: a new therapeutic target in chronic kidney disease | Q26776397 | ||
| Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties | Q27863422 | ||
| Vitamin E: function and metabolism | Q28138332 | ||
| Fatty acid import into mitochondria | Q28138465 | ||
| Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1 | Q28237795 | ||
| Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol | Q28298967 | ||
| Trace elements in hemodialysis patients: a systematic review and meta-analysis | Q28389374 | ||
| Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin | Q28477422 | ||
| A water soluble CoQ10 formulation improves intracellular distribution and promotes mitochondrial respiration in cultured cells | Q28481504 | ||
| Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients | Q28534658 | ||
| Expression of catalase and glutathione peroxidase in renal insufficiency | Q28570645 | ||
| Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney | Q28570995 | ||
| The roles of anabolic and catabolic reactions in the synthesis and recycling of polyunsaturated fatty acids | Q28609694 | ||
| Curcumin prevents mitochondrial dynamics disturbances in early 5/6 nephrectomy: Relation to oxidative stress and mitochondrial bioenergetics | Q28854321 | ||
| Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. | Q30925904 | ||
| Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment | Q31832598 | ||
| Protection by ascorbic acid from denaturation and release of cytochrome c, alteration of mitochondrial membrane potential and activation of multiple caspases induced by H(2)O(2), in human leukemia cells | Q33183601 | ||
| Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease | Q33495688 | ||
| AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol | Q33688533 | ||
| Identification of chronic kidney disease patient characteristics influencing the renoprotective effects of febuxostat therapy: a retrospective follow-up study | Q33706623 | ||
| Effect of selenium supplementation on glutathione peroxidase enzyme activity in patients with chronic kidney disease: a randomized clinical trial | Q33877178 | ||
| Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP. | Q33953637 | ||
| NAD+ and sirtuins in aging and disease | Q33955066 | ||
| CARNITINE HOMEOSTASIS, MITOCHONDRIAL FUNCTION, AND CARDIOVASCULAR DISEASE. | Q34002504 | ||
| Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. | Q34011073 | ||
| Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3 | Q34086829 | ||
| Coenzyme Q10 contents in foods and fortification strategies. | Q34105251 | ||
| Coenzyme Q--biosynthesis and functions | Q34116984 | ||
| α-Lipoic acid attenuates vascular calcification via reversal of mitochondrial function and restoration of Gas6/Axl/Akt survival pathway | Q37295751 | ||
| Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. | Q37335062 | ||
| Effect of different stages of chronic kidney disease and renal replacement therapies on oxidant-antioxidant balance in uremic patients | Q37422416 | ||
| Therapeutic Effects of Omega-3 Fatty Acids on Chronic Kidney Disease-Associated Pruritus: a Literature Review. | Q37590722 | ||
| Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1. | Q37593747 | ||
| Grapes, wines, resveratrol, and heart health | Q37601230 | ||
| Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis | Q37603998 | ||
| Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial | Q37604744 | ||
| A randomized controlled trial evaluating the erythropoiesis stimulating agent sparing potential of a vitamin E-bonded polysulfone dialysis membrane | Q37609720 | ||
| Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis | Q37614620 | ||
| Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy | Q37736609 | ||
| Trace element status in hemodialysis patients | Q37765934 | ||
| What we know about oxidative stress in patients with chronic kidney disease on dialysis--clinical effects, potential treatment, and prevention. | Q37837005 | ||
| KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. | Q38124594 | ||
| Safety and efficacy of allopurinol in chronic kidney disease | Q38164653 | ||
| Renal protective effects of resveratrol | Q38174888 | ||
| Effect of L-carnitine therapy on patients in maintenance hemodialysis: a systematic review and meta-analysis | Q38188908 | ||
| Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis | Q38191666 | ||
| Enhancing the delivery of resveratrol in humans: if low bioavailability is the problem, what is the solution? | Q38262965 | ||
| Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase | Q38283016 | ||
| Role of protein kinase C delta in curcumin-induced antioxidant response element-mediated gene expression in human monocytes. | Q38316154 | ||
| Carnitine in maintenance hemodialysis patients | Q38323717 | ||
| Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Ant | Q38396371 | ||
| Resveratrol prevents high glucose-induced epithelial-mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase/ROS/ERK pathway | Q38925447 | ||
| Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration. | Q39270481 | ||
| Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury | Q39339574 | ||
| High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol. | Q39412268 | ||
| The effect of selenium supplementation on acute phase reactants and thyroid function tests in hemodialysis patients. | Q39522227 | ||
| Suppression of NLRP3 Inflammasome Activation Ameliorates Chronic Kidney Disease-Induced Cardiac Fibrosis and Diastolic Dysfunction | Q39612410 | ||
| The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia | Q39988493 | ||
| Antioxidative and anti-inflammatory actions of docosahexaenoic acid and eicosapentaenoic acid in renal epithelial cells and macrophages | Q40103100 | ||
| Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin | Q40114458 | ||
| Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients | Q40432472 | ||
| New strategy of α- and γ-tocopherol to prevent contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures. | Q51838501 | ||
| Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway. | Q53077318 | ||
| Dialysis modality-dependent changes in serum metabolites: accumulation of inosine and hypoxanthine in patients on haemodialysis. | Q53458311 | ||
| Effects of alpha-lipoic acid on the plasma levels of asymmetric dimethylarginine in diabetic end-stage renal disease patients on hemodialysis: a pilot study. | Q53579779 | ||
| Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. | Q54179047 | ||
| Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells. | Q54309282 | ||
| Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure | Q57996800 | ||
| Diminished Selenium Levels in Hemodialysis and Continuous Ambulatory Peritoneal Dialysis Patients | Q59255792 | ||
| Curcumin maintains cardiac and mitochondrial function in chronic kidney disease | Q61192701 | ||
| IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of tocopherols and related compounds. Recommendations 1981 | Q70336356 | ||
| Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) | Q71060539 | ||
| Coenzyme Q10 levels, plasma lipids and peroxidation extent in renal failure and in hemodialytic patients | Q72243111 | ||
| Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial | Q73176018 | ||
| Radical scavenging activity of tea catechins and their related compounds | Q73300163 | ||
| Low whole blood and erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients | Q73782110 | ||
| Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids | Q73916539 | ||
| Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy | Q74084029 | ||
| Oxidative stress and plasma concentrations of coenzyme Q10, alpha-tocopherol, and beta-carotene in patients with a mild to moderate decrease of kidney function | Q74087836 | ||
| alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells | Q74382192 | ||
| Anemia and carnitine supplementation in hemodialyzed patients | Q74618833 | ||
| alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation | Q77604560 | ||
| Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats | Q79142160 | ||
| The pro-oxidant activity of high-dose vitamin E supplements in vivo | Q79199670 | ||
| Oxidative stress is progressively enhanced with advancing stages of CKD | Q79293648 | ||
| Vitamin E and selenium co-supplementation attenuates oxidative stress in haemodialysis patients receiving intra-dialysis iron infusion | Q79330329 | ||
| Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout | Q79750900 | ||
| Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection | Q80213574 | ||
| Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions | Q80800957 | ||
| Resveratrol attenuates cisplatin-induced nephrotoxicity in rats. | Q46890612 | ||
| L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis | Q46923243 | ||
| Resveratrol as a therapeutic agent for renal fibrosis induced by unilateral ureteral obstruction | Q46979246 | ||
| Effects of Coenzyme Q10 Supplementation on Exercise Performance and Markers of Oxidative Stress in Hemodialysis Patients: A Double-Blind Placebo-Controlled Crossover Trial. | Q47821792 | ||
| Vitamin C supplementation in kidney failure: effect on uraemic symptoms | Q49130066 | ||
| Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy. | Q50484759 | ||
| The green tea polyphenol (-)-epigallocatechin-3-gallate ameliorates experimental immune-mediated glomerulonephritis. | Q50521325 | ||
| Epigallocatechin-3-gallate protects kidneys from ischemia reperfusion injury by HO-1 upregulation and inhibition of macrophage infiltration. | Q50527406 | ||
| A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial. | Q50548448 | ||
| Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. | Q50723695 | ||
| Resveratrol attenuates skeletal muscle atrophy induced by chronic kidney disease via MuRF1 signaling pathway. | Q50739791 | ||
| Omega-3 Fatty Acid Supplementation is Associated With Oxidative Stress and Dyslipidemia, but Does not Contribute to Better Lipid and Oxidative Status on Hemodialysis Patients. | Q51039563 | ||
| Allopurinol for the treatment of chronic kidney disease: a systematic review | Q35195050 | ||
| NLRP3 inflammasome activation in dialyzed chronic kidney disease patients | Q35208558 | ||
| Resveratrol attenuates lipopolysaccharide-induced acute kidney injury by suppressing inflammation driven by macrophages | Q35572350 | ||
| Sirtuins and their relevance to the kidney. | Q35923139 | ||
| Vitamin E mediates cell signaling and regulation of gene expression. | Q36064390 | ||
| Sirtuins and renal diseases: relationship with aging and diabetic nephropathy | Q36304756 | ||
| The science behind dietary omega-3 fatty acids | Q36327949 | ||
| L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial. | Q36371108 | ||
| Omega-3 fatty acids and the regulation of expression of endothelial pro-atherogenic and pro-inflammatory genes | Q36386150 | ||
| Conjugated linoleic acid or omega 3 fatty acids increase mitochondrial biosynthesis and metabolism in skeletal muscle cells | Q36448426 | ||
| Biosynthesis of heme in mammals | Q36535259 | ||
| The protective effect of α-Lipoic acid on mitochondria in the kidney of diabetic rats. | Q36576560 | ||
| The antioxidant role of coenzyme Q. | Q36812583 | ||
| Human epicardial adipose tissue: a review | Q36836168 | ||
| The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview | Q36867029 | ||
| Mitochondrial dysfunction and oxidative stress in patients with chronic kidney disease. | Q36918729 | ||
| The effect of vitamin E-bonded polysulfone membrane dialyzer on a new oxidative lipid marker | Q36935026 | ||
| PGC-1α overexpression protects against aldosterone-induced podocyte depletion: role of mitochondria | Q37022134 | ||
| Short-Term High-Dose Vitamin E to Prevent Contrast Medium-Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo-Controlled Trial | Q37090807 | ||
| NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. | Q37202752 | ||
| Selenium: its role as antioxidant in human health | Q37232317 | ||
| Curcumin and the cellular stress response in free radical-related diseases. | Q37268964 | ||
| Renoprotective effect of the antioxidant curcumin: Recent findings. | Q37272692 | ||
| Pyruvate kinase type M2: a crossroad in the tumor metabolome | Q34118538 | ||
| Alpha-tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-alpha-mediated downregulation in human smooth muscle cells | Q34169724 | ||
| Human epicardial adipose tissue is a source of inflammatory mediators | Q34272633 | ||
| Biochemical, physiological and medical aspects of ubiquinone function | Q34298940 | ||
| Carnitine metabolism in uremia | Q34384714 | ||
| L-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysis | Q34394337 | ||
| Docosahexaenoic acid enhances the antioxidant response of human fibroblasts by upregulating gamma-glutamyl-cysteinyl ligase and glutathione reductase | Q34488939 | ||
| T channels and steroid biosynthesis: in search of a link with mitochondria | Q34535662 | ||
| Effects of L-carnitine supplementation in maintenance hemodialysis patients: a systematic review. | Q34539748 | ||
| Vitamin C enters mitochondria via facilitative glucose transporter 1 (Glut1) and confers mitochondrial protection against oxidative injury | Q34561378 | ||
| Antioxidant effect of L-carnitine and its short chain esters: relevance for the protection from oxidative stress related cardiovascular damage | Q34563169 | ||
| Febuxostat compared with allopurinol in patients with hyperuricemia and gout | Q34563183 | ||
| Fatty acids and lymphocyte functions | Q34564514 | ||
| Effect of curcumin on the induction of glutathione S-transferases and NADP(H):quinone oxidoreductase and its possible mechanism of action | Q34581128 | ||
| Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases | Q34594807 | ||
| Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets | Q34602448 | ||
| Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). | Q34615871 | ||
| Role of carnitine in disease | Q34618777 | ||
| Oxidative stress in hemodialysis patients: is NADPH oxidase complex the culprit? | Q34619578 | ||
| Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. | Q34629660 | ||
| Selenium and human health. | Q34636304 | ||
| From exotic spice to modern drug? | Q34679480 | ||
| Apoptotic pathways: the roads to ruin | Q34753431 | ||
| Effects of combination tocopherols and alpha lipoic acid therapy on oxidative stress and inflammatory biomarkers in chronic kidney disease | Q34806160 | ||
| Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review | Q34852823 | ||
| Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients | Q35022243 | ||
| Cross-over study of influence of oral vitamin C supplementation on inflammatory status in maintenance hemodialysis patients | Q35042578 | ||
| Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions | Q35066981 | ||
| Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference | Q35094875 | ||
| l-carnitine treatment of anemia | Q35129004 | ||
| Vitamin C in chronic kidney disease and hemodialysis patients | Q35138405 | ||
| The effect of selenium supplementation in the prevention of DNA damage in white blood cells of hemodialyzed patients: a pilot study | Q35154355 | ||
| Oxidative stress in end-stage renal disease: an emerging threat to patient outcome | Q35155017 | ||
| Green tea polyphenol (-)-epigallocatechin-3-gallate restores Nrf2 activity and ameliorates crescentic glomerulonephritis | Q35191850 | ||
| Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. | Q40552558 | ||
| Vitamin C inhibits FAS-induced apoptosis in monocytes and U937 cells | Q40665840 | ||
| NF-kappa B inhibition by omega -3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription | Q40696197 | ||
| Stability and structure of binary and ternary complexes of α-lipoate and lipoate derivatives with Mn2+, Cu2+, and Zn2+ in solution | Q40896634 | ||
| Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. | Q41854992 | ||
| Recycling of vitamin E in human low density lipoproteins | Q42028018 | ||
| Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling. | Q42177918 | ||
| The Relationship between Epicardial Adipose Tissue and Coronary Artery Calcification in Peritoneal Dialysis Patients | Q42262609 | ||
| Synergistic antibacterial effect of curcumin against methicillin-resistant Staphylococcus aureus | Q42268911 | ||
| Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats | Q42285179 | ||
| Ascorbate recycling in human erythrocytes: role of GSH in reducing dehydroascorbate | Q42552688 | ||
| Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling | Q42744612 | ||
| Effects of omega-3 on lipid profile and inflammation markers in peritoneal dialysis patients | Q42878436 | ||
| Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress | Q43108544 | ||
| Effects of L-carnitine on oxidative stress responses in patients with renal disease | Q43136371 | ||
| The effects of [omega]3 fatty acids and coenzyme Q10 on blood pressure and heart rate in chronic kidney disease: a randomized controlled trial | Q43286518 | ||
| Free radical scavenging by green tea polyphenols | Q43635874 | ||
| Carnitine as a free radical scavenger in aging | Q43774612 | ||
| Alpha-lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes | Q43829978 | ||
| Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study | Q43835478 | ||
| Effect of L-carnitine on brain lipid peroxidation and antioxidant enzymes in old rats | Q43928479 | ||
| Resveratrol, a component of wine and grapes, in the prevention of kidney disease | Q44035288 | ||
| Curcumin (diferuloylmethane), a singlet oxygen ((1)O(2)) quencher | Q44041028 | ||
| Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury | Q44067417 | ||
| Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency | Q44242769 | ||
| Epicardial fat thickness is associated with impaired coronary flow reserve in hemodialysis patients | Q44381291 | ||
| Blood 8-hydroxy-2'-deoxyguanosine is associated with erythropoietin resistance in haemodialysis patients | Q44397984 | ||
| In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa | Q44442246 | ||
| alpha-Lipoic acid: a metabolic antioxidant which regulates NF-kappa B signal transduction and protects against oxidative injury | Q44444269 | ||
| Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation | Q44488372 | ||
| Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial | Q44515187 | ||
| Selenium supplementation on plasma glutathione peroxidase activity in patients with end-stage chronic renal failure. | Q44741733 | ||
| Crystalline alpha-lipoic acid; a catalytic agent associated with pyruvate dehydrogenase | Q44760844 | ||
| Activity of (-)-epigallocatechin 3-O-gallate against oxidative stress in rats with adenine-induced renal failure | Q44821520 | ||
| Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study | Q44845974 | ||
| Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation | Q44945294 | ||
| Inhibition of transforming growth factor beta 1 induction by dietary vitamin E in unilateral ureteral obstruction in rats | Q45105846 | ||
| Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress | Q45165519 | ||
| Inflammation and carnitine in hemodialysis patients | Q45222182 | ||
| Curcumin reverses glomerular hemodynamic alterations and oxidant stress in 5/6 nephrectomized rats. | Q45835988 | ||
| Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease. | Q46035400 | ||
| Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor-kappaB. | Q46096844 | ||
| Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial | Q46271681 | ||
| Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy: a randomized controlled trial | Q46442055 | ||
| Hypoxia-reoxygenation-induced mitochondrial damage and apoptosis in human endothelial cells are inhibited by vitamin C. | Q46458401 | ||
| Antioxidant and radical scavenging properties of curcumin | Q46545266 | ||
| Effect of one-year oral alpha-tocopherol administration on the antioxidant defense system in hemodialysis patients | Q46575096 | ||
| Cardioprotection by curcumin post-treatment in rats with established chronic kidney disease. | Q46758479 | ||
| Antioxidant and antiradical activities of L-carnitine | Q46777344 | ||
| Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats | Q46803025 | ||
| Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis | Q46824003 | ||
| Increased phagocytic nicotinamide adenine dinucleotide phosphate oxidase-dependent superoxide production in patients with early chronic kidney disease. | Q46841643 | ||
| Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level | Q46867932 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inorganic compound | Q190065 |
| P577 | publication date | 2017-07-10 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease | |
| P478 | volume | 18 |
| Q61817225 | Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence? |
| Q60926275 | Beyond a Measure of Liver Function-Bilirubin Acts as a Potential Cardiovascular Protector in Chronic Kidney Disease Patients |
| Q92798237 | Combination Effect of Caffeine and Caffeic Acid Treatment on the Oxidant Status of Ectopic Endometrial Cells Separated from Patients with Endometriosis |
| Q57821381 | Effects of Hemodialysis on Thiol-Disulphide Homeostasis in Critically Ill Pediatric Patients with Acute Kidney Injury |
| Q59799492 | Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury |
| Q60939760 | Metformin: A Candidate Drug for Renal Diseases |
Search more.